| ID: | 146 | |
|---|---|---|
| Name: | Compound 146 | |
| Description: | Original numeration in publication: 7c | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C24H22N6OS/c1-2-25-24(32)30-29-23(31)17-12-14-18(15-13-17)26-22-20-11-7-6-10-19(20)21(27-28-22)16-8-4-3-5-9-16/h3-15H,2H2,1H3,(H,26,28)(H,29,31)(H2,25,30,32) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.77 |
El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278 |
| 6.86249 |
Eq1: VEGFR-2 inhibition (Data used to train model) |